BioSpace News Archive

Safety and efficacy of Essure® have not changed

5W Public Relations (5WPR), an award-winning and top 10 independently owned U.S. PR firm, announced today the launch of a cannabidiol (CBD) specialty team that will work across core practice areas including Health & Wellness, Beauty, Food & Beverage and Consumer.

EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, today announces the formation of its scientific advisory board (SAB). Evonetix has appointed Prof David Klenerman FMedSci FRS and Prof Andrew Briggs to advise the Company on key focus areas in synthetic biology and bioethics, to support the development of its novel DNA synthesis platform.

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the R&D company focused on delivering innovative oncology and rare disease products to patients, today announces an agreement with a major regional corporation (“the Partner”), in which the Partner will evaluate Midatech’s Q-Sphera™ microsphere sustained release technology for use with the Partner’s materials.

G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced positive topline data showing multi-lineage myelopreservation benefits in its randomized, double-blind, placebo-controlled Phase 2 trial evaluating trilaciclib in combination with topotecan as a treatment for 2nd-/3rd-line small cell lung cancer (2/3L SCLC).

Proprietary, cfRNA-enriched, real-time PCR testing rapidly identifies all patients with NTRK fusion-positive cancers potentially eligible for new TRK inhibitor targeted therapy

Preventing, Recognizing and Mitigating Mycotoxin Contamination

The National Board of Osteopathic Medical Examiners (NBOME) is pleased to announce the 2018 recipients of its awards which honors individuals making significant contributions to the NBOME’s mission to protect the public by assessing competencies for osteopathic medicine and related health care professions.

Two highly-regarded healthcare organizations joining together on January 1, 2019

Research Shows Rebates Unrelated to Drug Manufacturer Pricing Strategies